Lamparter Steffen, Grimm Wolfram
Department of Cardiology, Hospital of the Philipps-University of Marburg, Germany.
Pacing Clin Electrophysiol. 2005 Jan;28 Suppl 1:S233-6. doi: 10.1111/j.1540-8159.2005.00034.x.
We analyzed the serum concentrations of high-sensitivity C-reactive protein (hsCRP) at the time of diagnostic cardiac catheterization in 198 patients with idiopathic dilated cardiomyopathy (IDC) to evaluate its prognostic value. Patients were dichotomized according to a median value of hsCRP of 2 mg/dL. Predefined study endpoints over 69 +/- 33 months of follow-up included major arrhythmic events and transplant-free survival. Major arrhythmic events during follow-up occurred in 20 of 98 patients (20%) with low, compared to 22 of 100 patients (22%) with high hsCRP (ns). By multivariate analysis, a depressed left ventricular ejection fraction (LVEF) was the only significant predictor of arrhythmic risk. Death or cardiac transplantation was observed in 36% of patients with high, versus 22% of patients with low hsCRP (P < 0.05). By multivariate analysis, hsCRP and LVEF were independent predictors of transplant-free survival. Thus, in this patient population with IDC, hsCRP had independent prognostic value with regard to transplant-free survival, but did not contribute in the stratification with regard to arrhythmic risk.
我们分析了198例特发性扩张型心肌病(IDC)患者在诊断性心导管检查时的血清高敏C反应蛋白(hsCRP)浓度,以评估其预后价值。根据hsCRP中位数2mg/dL将患者分为两组。在69±33个月的随访中,预先设定的研究终点包括主要心律失常事件和无移植生存。随访期间,hsCRP低的98例患者中有20例(20%)发生主要心律失常事件,而hsCRP高的100例患者中有22例(22%)发生(无显著性差异)。多因素分析显示,左心室射血分数(LVEF)降低是心律失常风险的唯一显著预测因素。hsCRP高的患者中有36%死亡或接受心脏移植,而hsCRP低的患者中这一比例为22%(P<0.05)。多因素分析显示,hsCRP和LVEF是无移植生存的独立预测因素。因此,在这群IDC患者中,hsCRP在无移植生存方面具有独立的预后价值,但在心律失常风险分层方面并无作用。